Intelence Now for Kids Ages 6 and OlderMay/June 2012 The HIV drug Intelence (etravirine) received approval from the Food and Drug Administration (FDA) for use by children ages six to 18 weighing at least 35 pounds, who have previous anti-HIV treatment experience. This includes children whose virus has developed drug resistance to the same class of medications as Intelence (non-nucleoside reverse transcriptase inhibitors, or NNRTIs). Sustiva and Viramune are the NNRTIs previously available for pediatric use. A new scored 25 mg tablet of Intelence is now available for pediatrics. For more information about the drug, go to www.positivelyaware.com/intelence View Full Article![]() Intelence (Etravirine): Pediatric Dosing Recommendations and New Scored 25 mg Tablet for Pediatric Dosing Visit TPAN's website to find out more about their activities, publications and services.
Comment by: dailyrx
Thu., Jan. 3, 2013 at 11:43 am EST According to http://www.rxwiki.com/intelence, the drug is meant to be used in combination with other meds. What other medications have been approved for children?
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|